NCT01634750View on ClinicalTrials.gov

Phase I Clinical Trial of ManNAc in Patients With GNE Myopathy or Hereditary Inclusion Body Myopathy (HIBM)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 11, 2012

Study Completion Date

May 29, 2013

Conditions

Hereditary Inclusion Body Myopathy (HIBM)GNE Myopathy

Interventions

DRUG

ManNAc

Single dose

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors

collaborator

National Center for Advancing Translational Sciences (NCATS)

NIH

collaborator

Therapeutics for Rare and Neglected Diseases (TRND)

NIH

lead

National Human Genome Research Institute (NHGRI)

NIH

NCT01634750 - Phase I Clinical Trial of ManNAc in Patients With GNE Myopathy or Hereditary Inclusion Body Myopathy (HIBM) | Biotech Hunter | Biotech Hunter